271 related articles for article (PubMed ID: 8097249)
21. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients.
Guillevin L; Mahr A; Callard P; Godmer P; Pagnoux C; Leray E; Cohen P;
Medicine (Baltimore); 2005 Sep; 84(5):313-322. PubMed ID: 16148731
[TBL] [Abstract][Full Text] [Related]
22. [Durability of HBeAg seroconversion in lamivudine treatment of chronic hepatitis B patients].
Zhu M; Xu B; Yao GB
Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):534-6. PubMed ID: 16042894
[TBL] [Abstract][Full Text] [Related]
23. An open-label study of lamivudine for chronic hepatitis B in six patients with chronic renal failure before and after kidney transplantation.
Ben-Ari Z; Broida E; Kittai Y; Chagnac A; Tur-Kaspa R
Am J Gastroenterol; 2000 Dec; 95(12):3579-83. PubMed ID: 11151895
[TBL] [Abstract][Full Text] [Related]
24. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
Seehofer D; Rayes N; Steinmüller T; Müller AR; Settmacher U; Neuhaus R; Radke C; Berg T; Hopf U; Neuhaus P
Liver Transpl; 2001 Nov; 7(11):976-82. PubMed ID: 11699034
[TBL] [Abstract][Full Text] [Related]
25. Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa.
Guillevin L; Jarrousse B; Lok C; Lhote F; Jais JP; Le Thi Huong Du D; Bussel A
J Rheumatol; 1991 Apr; 18(4):567-74. PubMed ID: 1676753
[TBL] [Abstract][Full Text] [Related]
26. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
Lu H; Ma LX; Xu WS; Zhang HY; Yu LJ; Duan HY
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):173-5. PubMed ID: 12681068
[TBL] [Abstract][Full Text] [Related]
27. Long-term lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety.
Jonas MM; Little NR; Gardner SD;
J Viral Hepat; 2008 Jan; 15(1):20-7. PubMed ID: 18088241
[TBL] [Abstract][Full Text] [Related]
28. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
[TBL] [Abstract][Full Text] [Related]
29. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
Ben-Ari Z; Mor E; Shapira Z; Tur-Kaspa R
Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394
[TBL] [Abstract][Full Text] [Related]
30. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352
[TBL] [Abstract][Full Text] [Related]
31. [Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B].
Janssen HL; Berk L; de Man RA; Heijtink RA; Schalm SW
Ned Tijdschr Geneeskd; 1992 Apr; 136(17):835-9. PubMed ID: 1522928
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
Sakai T; Shiraki K; Inoue H; Okano H; Deguchi M; Sugimoto K; Ohmori S; Murata K; Nakano T
Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559
[TBL] [Abstract][Full Text] [Related]
33. [Clinical study of lamivudine and interferon combinate administration to inhibit hepatitis B virus replication].
Song JW; Zhang G; Lin JG; Tang WX; Lin JS
Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):593-6. PubMed ID: 15504288
[TBL] [Abstract][Full Text] [Related]
34. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of alpha interferon for the treatment of chronic hepatitis B infection in Christchurch.
Burt MJ; Ross AG; Schroeder BA; Chambers ST; Chapman BA
N Z Med J; 1996 May; 109(1021):162-4. PubMed ID: 8657367
[TBL] [Abstract][Full Text] [Related]
36. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database.
Pagnoux C; Seror R; Henegar C; Mahr A; Cohen P; Le Guern V; Bienvenu B; Mouthon L; Guillevin L;
Arthritis Rheum; 2010 Feb; 62(2):616-26. PubMed ID: 20112401
[TBL] [Abstract][Full Text] [Related]
37. Gastrointestinal tract involvement in polyarteritis nodosa and Churg-Strauss syndrome.
Guillevin L; Lhote F; Gallais V; Jarrousse B; Royer I; Gayraud M; Benichou J
Ann Med Interne (Paris); 1995; 146(4):260-7. PubMed ID: 7653948
[TBL] [Abstract][Full Text] [Related]
38. Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients.
Ribi C; Cohen P; Pagnoux C; Mahr A; Arène JP; Puéchal X; Carli P; Kyndt X; Le Hello C; Letellier P; Cordier JF; Guillevin L;
Arthritis Rheum; 2010 Apr; 62(4):1186-97. PubMed ID: 20131268
[TBL] [Abstract][Full Text] [Related]
39. Polyarteritis nodosa associated with hepatitis B virus infection. The role of antiviral treatment and mutations in the hepatitis B virus genome.
Janssen HL; van Zonneveld M; van Nunen AB; Niesters HG; Schalm SW; de Man RA
Eur J Gastroenterol Hepatol; 2004 Aug; 16(8):801-7. PubMed ID: 15256984
[TBL] [Abstract][Full Text] [Related]
40. Treatment of hepatitis B virus-related polyarteritis nodosa: two case reports and a review of the literature.
Deeren DH; De Backer AI; Malbrain ML; Verbraeken H; Blockmans D
Clin Rheumatol; 2004 Apr; 23(2):172-6. PubMed ID: 15045636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
